ADMA Biologics Completes Merger and Closes $17.5 Million Private Placement – Yahoo Finance
ADMA Biologics, Inc. (“ADMA”), a clinical stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced the completion of a reverse merger with R&R Acquisition ...
Subscribe to LegalLaw247.Com Newsletter